An appeals court recently ruled that Johnson & Johnson deserves a new trial after the company was ordered by a jury to pay $417 million to a woman who alleged her cancer was caused by her use of the company’s Baby Powder. Despite there being enough evidence to uphold the ruling that the company did not warn the public of the potential health risks associated with the use of talc-based products, the appeals court found there was “conflicting evidence” regarding …

Users of the Type 2 diabetes medication Onglyza claim the drug causes heart failure and the drug’s manufacturer knew of the risk and failed to warn consumers. The most recent lawsuit, filed by Texas man Wrendell Chester against Bristol-Myers Squibb and AstraZeneca, claims his heart failure was caused by use of the drug. According to the lawsuit, Chester took Onglyza and Kombiglyze XR between 2010 and 2015. Following his use of the drugs, he suffered congestive heart failure and heart …

Some users of the rheumatoid arthritis drug Actemra are taking legal action against the drug’s manufacturer after their use of it led to cardiovascular incidents. The drug has been linked to reports of stroke, heart attack, and heart failure, as well as incidences of acute pancreatitis and interstitial lung disease. There are concerns that the potentially life threatening side effects linked to Actemra were not disclosed by the drug’s maker or included on the drug’s packaging despite the manufacturer knowing …

Users of the antipsychotic medication Abilify might be eligible to receive money from a global settlement reached by the company this past February. According to the court order, issued in mid-February 2019, all lawyers for plaintiffs in the cases will need to appear for a case management conference to resolve the lawsuits pending in federal courts throughout the country. Claims administrators have been appointed to the case and settlement deadlines have been set. The terms of the settlement are private …

The state of New York has filed a lawsuit against Purdue Pharma claiming the pharmaceutical company intentionally triggered the opioid epidemic by way of their marketing campaign. Purdue Pharma recently settled a similar lawsuit and agreed to pay the state of Oklahoma, while a number of other similar lawsuits are pending in courts across the country. OxyContin Marketing Called into Question According to the New York lawsuit, Purdue Pharma’s marketing of its OxyContin painkiller triggered the addiction epidemic faced by …

Tasigna, which also goes by the name nilotinib, is a medication used to treat patients with a specific type of incessant, curable form of leukemia. Many consider it as a last-resort treatment because it is used after other treatment has been unsuccessful. What is Chromosome-positive Chronic Myeloid Leukemia? Chromosome-positive Chronic Myeloid Leukemia (CML) is a type of cancer. It’s curable but can become chronic if not treated properly. It causes a person’s bone marrow to produce too many white blood …